Zhou Ying-qun, Chen Shi-yao, Jiang Lin-di, Guo Chuan-yong, Shen Zhen-yu, Huang Pei-xing, Wang Ji-yao
Department of Digestion, Tenth People's Hospital, Tong Ji University, Zhabei District, Shanghai, China.
J Gastroenterol Hepatol. 2009 Mar;24(3):408-15. doi: 10.1111/j.1440-1746.2008.05678.x. Epub 2008 Dec 1.
The objective was to develop a valid and reliable health-related quality of life (HRQOL) assessment tool to measure the functional and health status of patients with minimal hepatic encephalopathy (mHE).
Items potentially affecting the HRQOL of these patients were identified, based on the responses from 53 patients with minimal hepatic encephalopathy, from seven liver experts, four epidemiologists and from a PubMed search of the literature. Results were explored using factor analysis and redundant questions were eliminated. The final stated questionnaire was used in 178 patients with mHE to evaluate its reliability and validity.
Thirty-five items proved to be important for 32 respondents in the item reduction sample. The final instrument included five domains (30 items) which were shown as follows: physical functioning (8 items), psychological well-being (7 items), symptoms/side effects (7 items), social functioning (4 items) and general-health (4 items). An inter-item correlation for each of the five domains ranged from 0.220 to 0.776, with a mean of 0.280. Cronbach's alpha for above five domains was 0.8775, 0.8446, 0.8360, 0.7087 and 0.7016 respectively. The test-retest coefficients for the five domains were 0.94, 0.93, 0.96, 0.82 and 0.83 respectively. Factor analysis showed preservation of five components structure. Cumulative variance of principal components was 63.12%. Patients with more advanced disease seemed to have more impairment of their well-being, especially in the symptoms/side effects domain.
The instrument is short, easy to administer and is of good validity and reliability in patients with mHE.
开发一种有效且可靠的健康相关生活质量(HRQOL)评估工具,以测量轻微肝性脑病(mHE)患者的功能和健康状况。
基于53例轻微肝性脑病患者的回答、七位肝脏专家、四位流行病学家的意见以及对PubMed文献的检索,确定可能影响这些患者健康相关生活质量的项目。使用因子分析探索结果并消除冗余问题。最终确定的问卷用于178例轻微肝性脑病患者,以评估其可靠性和有效性。
在项目缩减样本中,35个项目对32名受访者来说是重要的。最终工具包括五个领域(30个项目),具体如下:身体功能(8个项目)、心理健康(7个项目)、症状/副作用(7个项目)、社会功能(4个项目)和总体健康(4个项目)。五个领域中每个领域的项目间相关性范围为0.220至0.776,平均值为0.280。上述五个领域的克朗巴哈系数分别为0.8775、0.8446、0.8360、0.7087和0.7016。五个领域的重测系数分别为0.94、0.93、0.96、0.82和0.83。因子分析显示保留了五个成分结构。主成分的累积方差为63.12%。疾病进展较严重的患者似乎幸福感受损更严重,尤其是在症状/副作用领域。
该工具简短、易于实施,对轻微肝性脑病患者具有良好的有效性和可靠性。